We are live on
!
Find out more
IG
Ithaka Group Portfolio holdings
AUM
$482M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
+15.81%
3 Year Est. Return
+99.18%
5 Year Est. Return
+112.16%
10 Year Est. Return
+745.06%
AUM
$632M
AUM Growth
-$6.08M
(-0.95%)
Cap. Flow
-$55.4M
Cap. Flow
% of AUM
-8.77%
Top 10 Holdings %
Top 10 Hldgs %
47.21%
Holding
46
New
3
Increased
8
Reduced
26
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$13.6M |
| 2 |
Palo Alto Networks
PANW
|
+$5.7M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$5.34M |
| 4 |
Biogen
BIIB
|
+$4.61M |
| 5 |
Middleby
MIDD
|
+$3.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$27.2M |
| 2 |
Cummins
CMI
|
+$15.3M |
| 3 |
Las Vegas Sands
LVS
|
+$13.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.98M |
| 5 |
Starbucks
SBUX
|
+$2.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.25% |
| 2 | Communication Services | 22.8% |
| 3 | Healthcare | 15.25% |
| 4 | Technology | 12.87% |
| 5 | Financials | 8.11% |
Similar funds
SDWIA
BAG
EFA
MAM
NQWM
BAM
BWA
HC
Ithaka Group's Q1 2015 Portfolio in Review
As of Q1 2015, Ithaka Group held 46 positions worth $632M, down 0.95% from $638M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Ithaka Group withdrew a net $55.4M in Q1 2015, closing 4 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $27.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Ithaka Group opened a new position in TJX Companies worth $13.9M.
- Ithaka Group's largest Q1 2015 buy was TJX Companies: 398,194 shares worth $13.9M.
- Ithaka Group added most to Biogen in Q1 2015, an estimated $4.61M increase.
- Ithaka Group's biggest Q1 2015 reduction was Las Vegas Sands, cutting an estimated $13.9M.
- Ithaka Group fully exited Gilead Sciences in Q1 2015, selling an estimated $27.2M.
- Ithaka Group's ten largest holdings make up 47% of its $632M portfolio in Q1 2015.
- Ithaka Group opened 3 new positions and closed 4 in Q1 2015.
- Ithaka Group's portfolio value fell 0.95% quarter-over-quarter to $632M.
Based on Ithaka Group's 13F filing for Q1 2015, filed 11 May 2015.